{
    "id": 32698,
    "fullName": "LIFR positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "LIFR positive indicates the presence of the LIFR gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3977,
        "geneSymbol": "LIFR",
        "terms": [
            "LIFR",
            "CD118",
            "LIF-R",
            "SJS2",
            "STWS",
            "SWS"
        ]
    },
    "variant": "positive",
    "createDate": "03/04/2020",
    "updateDate": "03/04/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20734,
            "approvalStatus": "Preclinical - Pdx",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, EC359 treatment inhibited Mtor/Akt signaling and reduced tumor progression in a patient-derived xenograft (PDX) model of LIFR expressing triple-receptor negative breast cancer (PMID: 31142661).",
            "molecularProfile": {
                "id": 35315,
                "profileName": "LIFR positive"
            },
            "therapy": {
                "id": 9439,
                "therapyName": "EC359",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 18017,
                    "pubMedId": 31142661,
                    "title": "EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31142661"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35315,
            "profileName": "LIFR positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}